General information about company

Name of The CompanyANG Lifesciences India Limited
BSE Scrip Code540694
NSE Symbol
MSE Symbol
Date of Start of Financial Year01-04-2023
Date of End of Financial Year31-03-2024
Reporting PeriodSecond half yearly
Date of Start of Reporting Period01-10-2023
Date of End of Reporting Period31-03-2024
Level of rounding to be used in disclosing related party transactionsLakhs
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNo
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1ANG Lifesciences India LimitedAAHCA5390HRajesh GuptaAAQPG4797CPromoterRemunerationAs approved by Audit committee54-9.43-2.6Textual Information(1)
2ANG Lifesciences India LimitedAAHCA5390HSaruchi GuptaALAPG5323RPromoterRemunerationAs approved by Audit committee271.150.54Textual Information(2)
3ANG Lifesciences India LimitedAAHCA5390HRohit MittalAOEPM0226JDirectorAny other transactionSitting feesAs approved by Audit committee0.2500Textual Information(3)
4ANG Lifesciences India LimitedAAHCA5390HPawanjit SinghACUPS4040CDirectorAny other transactionSitting feesAs approved by Audit committee0.100Textual Information(4)
5ANG Lifesciences India LimitedAAHCA5390HSukhpal SinghABMPS4053NDirectorAny other transactionSitting feesAs approved by Audit committee0.2500Textual Information(5)
6ANG Lifesciences India LimitedAAHCA5390HChetnaAVEPC8499ADirectorAny other transactionSitting feesAs approved by Audit committee0.2500.25Textual Information(6)
7ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiarySale of goods or servicesAs approved by Audit committee61.1300.02Textual Information(7)
8ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiaryPurchase of goods or servicesAs approved by Audit committee261.41-428.12-186.13Textual Information(8)
9ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiaryAny other transactioncommissionAs approved by Audit committee6.859.740Textual Information(9)
10ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiaryAny other transactionGuaranteeAs approved by Audit committee0.9400Textual Information(10)
11ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiaryAny other transactionInterest ReceivedAs approved by Audit committee13.47212.41349.53Textual Information(11)
12ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiaryAny other transactionTDS ReceivedAs approved by Audit committee1.3400Textual Information(12)
13ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt Ltd AAOCA3292RCompany's promoter significant influenceSale of goods or servicesAs approved by Audit committee480.241978.771659.34Textual Information(13)
14ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt Ltd AAOCA3292RCompany's promoter significant influencePurchase of goods or servicesAs approved by Audit committee2.2700Textual Information(14)
15ANG Lifesciences India LimitedAAHCA5390HANG Healthcare India Pvt Ltd AAOCA3292RCompany's promoter significant influenceAny other transactionInterest ReceivedAs approved by Audit committee2.72-89.82-92.53Textual Information(15)
16ANG Lifesciences India LimitedAAHCA5390HANG Capital Investments Pvt Ltd AAWCA6542JCompany's promoter significant influenceAny other transactionAdvance As approved by Audit committee010.70Textual Information(16)
17ANG Lifesciences India LimitedAAHCA5390HANG Capital Investments Pvt Ltd AAWCA6542JCompany's promoter significant influenceAny other transactionAdvance taken backAs approved by Audit committee10.700Textual Information(17)
18ANG Lifesciences India LimitedAAHCA5390HANG Energy Ltd AAVCA9883FCompany's promoter significant influenceAny other transactionAdvance taken backAs approved by Audit committee0.40.40Textual Information(18)
19ANG Lifesciences India LimitedAAHCA5390HANG Health Solutions Pvt LtdAAYCA0635NCompany's promoter significant influenceSale of goods or servicesAs approved by Audit committee0.9300Textual Information(19)
20ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's promoter significant influenceAny other transactionAdvance As approved by Audit committee457.7400Textual Information(20)
21ANG Lifesciences India LimitedAAHCA5390HRecorders & Medicare Systems Pvt LtdAACCR6241BCompany's promoter significant influenceAny other transactionAdvance taken backAs approved by Audit committee116.790-340.95Textual Information(21)
22ANG Lifesciences India LimitedAAHCA5390HRenatus Meditech Solutions Pvt Ltd AAKCR1772RCompany's promoter significant influenceAny other transactionAdvanceAs approved by Audit committee10.9587.3797.92Textual Information(22)
23ANG Lifesciences India LimitedAAHCA5390HRenatus Meditech Solutions Pvt Ltd AAKCR1772RCompany's promoter significant influenceAny other transactionAdvance taken backAs approved by Audit committee0.400Textual Information(23)
24ANG Lifesciences India LimitedAAHCA5390HRenu KaurCJIPK0609NCompany SecretaryRemunerationNot required 2.880.520.8Textual Information(24)
25ANG Lifesciences India LimitedAAHCA5390HMansa Print & Publishers LimitedAADCM9521EWholly Owned SubsidiaryAdvanceAs approved by Audit committee12500Textual Information(25)
26ANG Lifesciences India LimitedAAHCA5390HBaddi Agro Private Limited AAJCB7928ECompany's promoter significant influenceAdvanceAs approved by Audit committee01432.781432.78Textual Information(26)
Total value of transaction during the reporting period1638.01